MedPath

NOVEM PHARMA PRIVATE LIMITED

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

63

HSA:63

Drug Approvals

ARIPIPRAZOLE MEVON TABLETS 15 MG

Approval Date
Feb 18, 2025
HSA

ARIPIPRAZOLE MEVON TABLETS 5 MG

Approval Date
Feb 18, 2025
HSA

ARIPIPRAZOLE MEVON TABLETS 10 MG

Approval Date
Feb 18, 2025
HSA

ANAGRELIDE MEVON CAPSULES 0.5 MG

Approval Date
Oct 17, 2024
HSA

EPLERENONE MEVON FILM-COATED TABLETS 50 MG

Approval Date
Feb 6, 2024
HSA

EPLERENONE MEVON FILM-COATED TABLETS 25 MG

Approval Date
Feb 6, 2024
HSA

ROZEVON FILM-COATED TABLET 40MG/10MG

Approval Date
Jul 4, 2022
HSA

ROZEVON FILM-COATED TABLET 20MG/10MG

Approval Date
Jul 4, 2022
HSA

ROZEVON FILM-COATED TABLET 10MG/10MG

Approval Date
Jul 4, 2022
HSA

ROZEVON FILM-COATED TABLET 5MG/10MG

Approval Date
Jul 4, 2022
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.